Literature DB >> 15501753

Differential expression of porins OmpP2A and OmpP2B of Haemophilus ducreyi.

Derrick T Prather1, Manjeet Bains, Robert E W Hancock, Melanie J Filiatrault, Anthony A Campagnari.   

Abstract

Haemophilus ducreyi is a strict human pathogen and the causative agent of the sexually transmitted disease chancroid. The genome of the human-passaged strain of H. ducreyi (35000HP) contains two homologous genes whose protein products have estimated molecular masses of 46 and 43 kDa. A comparative analysis of the deduced amino acid sequences revealed that these proteins share 27 to 33% identity to the outer membrane protein P2 (OmpP2), a major porin of Haemophilus influenzae. Therefore, these proteins have been designated OmpP2A and OmpP2B, respectively. The detection of ompP2A and ompP2B transcripts by reverse transcriptase PCR indicated that these genes were independently transcribed in H. ducreyi 35000HP. Western blot analysis of outer membrane proteins isolated from a geographically diverse collection of H. ducreyi clinical isolates revealed that OmpP2A and OmpP2B were differentially expressed among these strains. Although PCR analysis suggested that ompP2A and ompP2B were conserved among the strains tested, the differential expression observed was due to nucleotide additions and partial gene deletions. Purified OmpP2A and OmpP2B were isolated under nondenaturing conditions, and subsequent analysis demonstrated that these two proteins exhibited porin activity. OmpP2A and OmpP2B are the first porins described for H. ducreyi.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501753      PMCID: PMC523061          DOI: 10.1128/IAI.72.11.6271-6278.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Antibodies to loop 6 of the P2 porin protein of nontypeable Haemophilus influenzae are bactericidal against multiple strains.

Authors:  J M Neary; K Yi; R J Karalus; T F Murphy
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Haemophilus influenzae porin contributes to signaling of the inflammatory cascade in rat brain.

Authors:  M Galdiero; M D'Amico; F Gorga; C Di Filippo; M D'Isanto; M Vitiello; A Longanella; A Tortora
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 3.  Multiple facets of bacterial porins.

Authors:  W Achouak; T Heulin; J M Pagès
Journal:  FEMS Microbiol Lett       Date:  2001-05-15       Impact factor: 2.742

4.  Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line.

Authors:  G E Wood; S M Dutro; P A Totten
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Diversity of the outer membrane protein P2 gene from major clones of Haemophilus influenzae type b.

Authors:  R Munson; C Bailey; S Grass
Journal:  Mol Microbiol       Date:  1989-12       Impact factor: 3.501

6.  Porins from Salmonella enterica serovar Typhimurium induce TNF-alpha, IL-6 and IL-8 release by CD14-independent and CD11a/CD18-dependent mechanisms.

Authors:  Marilena Galdiero; Marina D'Isanto; Mariateresa Vitiello; Emiliana Finamore; Lucia Peluso; Massimiliano Galdiero
Journal:  Microbiology       Date:  2001-10       Impact factor: 2.777

7.  Serum resistance in Haemophilus ducreyi requires outer membrane protein DsrA.

Authors:  C Elkins; K J Morrow; B Olsen
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC mutants in in vitro and in vivo systems.

Authors:  D A Lewis; M K Stevens; J L Latimer; C K Ward; K Deng; R Blick; S R Lumbley; C A Ison; E J Hansen
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

9.  Eradicating chancroid.

Authors:  R Steen
Journal:  Bull World Health Organ       Date:  2001-10-23       Impact factor: 9.408

10.  Evaluation of an isogenic major outer membrane protein-deficient mutant in the human model of Haemophilus ducreyi infection.

Authors:  R E Throm; J A Al-Tawfiq; K R Fortney; B P Katz; A F Hood; C A Slaughter; E J Hansen; S M Spinola
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

View more
  7 in total

1.  Regulation of expression of the Haemophilus ducreyi LspB and LspA2 proteins by CpxR.

Authors:  Maria Labandeira-Rey; Jason R Mock; Eric J Hansen
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

2.  Comparative proteomic analysis of the Haemophilus ducreyi porin-deficient mutant 35000HP::P2AB.

Authors:  Jeremiah J Davie; Anthony A Campagnari
Journal:  J Bacteriol       Date:  2008-12-19       Impact factor: 3.490

3.  Characterization and comparative analysis of the genes encoding Haemophilus parasuis outer membrane proteins P2 and P5.

Authors:  Michael A Mullins; Karen B Register; Darrell O Bayles; Crystal L Loving; Tracy L Nicholson; Susan L Brockmeier; David W Dyer; Gregory J Phillips
Journal:  J Bacteriol       Date:  2009-07-24       Impact factor: 3.490

4.  Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells.

Authors:  Wei Li; Barry P Katz; Stanley M Spinola
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

5.  Activation of the CpxRA system by deletion of cpxA impairs the ability of Haemophilus ducreyi to infect humans.

Authors:  Stanley M Spinola; Kate R Fortney; Beth Baker; Diane M Janowicz; Beth Zwickl; Barry P Katz; Robert J Blick; Robert S Munson
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

6.  Characterization of the CpxRA regulon in Haemophilus ducreyi.

Authors:  Maria Labandeira-Rey; Chad A Brautigam; Eric J Hansen
Journal:  Infect Immun       Date:  2010-08-30       Impact factor: 3.441

7.  A (p)ppGpp-null mutant of Haemophilus ducreyi is partially attenuated in humans due to multiple conflicting phenotypes.

Authors:  Concerta Holley; Dharanesh Gangaiah; Wei Li; Kate R Fortney; Diane M Janowicz; Sheila Ellinger; Beth Zwickl; Barry P Katz; Stanley M Spinola
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.